Owners, management and financials
CVR: 34224781
Secondary names: ASTION A/S, ASTION INFLAMMATION A/S, ASTION DANMARK A/S
Previous names: AP NEWCO A/S
DKK -18,071
Gross profit
Net result: DKK -164,736
KAPITALFORMIDLINGS INSTITUTTET A/S (100%)
CVR · view owners
Torben Rønje
Board: Ib Henrik Rønje (chair) and 2 members
CVR · view management
Active
Founded 27 January 2012
CVR · view overview
0 employees
CVR · 2017
Director registered: Torben Rønje
CVR · 12/08/2026
View the full event history
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.
Selskabets formål er investering i og besiddelse af ejendomme, værdipapirer og kapitalandele, herunder via indirekte erhvervelser, investeringer og udlån samt anden hermed beslægtet virksomhed efter bestyrelsens nærmere skøn.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -18 t. | -165 t. | 783 t. | -6 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | -116 t. | -246 t. | 3 mio. | -5.8 mio. | - | |
| 202301/01/2023 – 31/12/2023 | 132 t. | 11 t. | 3 mio. | -5.5 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 206 t. | 25 t. | 3 mio. | -5.6 mio. | - | |
| 202101/01/2021 – 31/12/2021 | -1.4 mio. | -6.3 mio. | 3.6 mio. | -5.6 mio. | - | |
| 202001/01/2020 – 31/12/2020 | -3.6 mio. | -4.8 mio. | 10.5 mio. | 697 t. | - | |
| 201901/01/2019 – 31/12/2019 | -1.8 mio. | -1.8 mio. | - | - | - | |
| 201801/01/2018 – 31/12/2018 | -392 t. | -409 t. | - | 500 t. | - | |
| 201701/01/2017 – 31/12/2017 | -48 t. | -1.5 mio. | 10.8 mio. | 7.7 mio. | 0 | |
| 201601/01/2016 – 31/12/2016 | -187 t. | 117 t. | 16.9 mio. | 15.7 mio. | 0 | |
| 201501/01/2015 – 31/12/2015 | -783 t. | -5.8 mio. | 17.4 mio. | 15.6 mio. | - | |
| 201401/01/2014 – 31/12/2014 | -1.2 mio. | -3.4 mio. | 43.5 mio. | 21.3 mio. | - | |
| 201301/01/2013 – 31/12/2013 | -804 t. | -1.5 mio. | 42.3 mio. | 24.8 mio. | - | |
| 201227/01/2012 – 31/12/2012 | -1.1 mio. | -1.9 mio. | 37.2 mio. | 26.3 mio. | - |
Compared to 20.625 companies in Anden finansiel formidling i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of ASTION PHARMA A/S is 34224781.
ASTION PHARMA A/S is owned by KAPITALFORMIDLINGS INSTITUTTET A/S.
The management of ASTION PHARMA A/S consists of Torben Rønje.
The board of ASTION PHARMA A/S consists of Ib Henrik Rønje, Henrik Grønfeldt-Sørensen and Torben Rønje, with Ib Henrik Rønje as chair.
In 2025, ASTION PHARMA A/S reported a gross profit of DKK -18,071.
ASTION PHARMA A/S had 0 employees in 2017 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
As of August 12, 2026, Torben Rønje has joined the board of directors of ASTION PHARMA A/S.
As of August 12, 2026, Ib Henrik Rønje has joined the board of directors of ASTION PHARMA A/S.
As of August 12, 2026, Henrik Grønfeldt-Sørensen has joined the board of directors of ASTION PHARMA A/S.
As of August 12, 2026, Jens Heimburger has left the board of directors of ASTION PHARMA A/S.
As of August 12, 2026, Torben Rønje is registered as director of ASTION PHARMA A/S.
As of August 12, 2026, Morten Bo Madsen has stepped down as director of ASTION PHARMA A/S.
As of August 12, 2026, Jan Kruse Hansen has stepped down as director of ASTION PHARMA A/S.
As of August 11, 2026, Torben Rønje has left the board of directors of ASTION PHARMA A/S.
As of August 11, 2026, Ib Henrik Rønje has left the board of directors of ASTION PHARMA A/S.
As of June 15, 2026, KAPITALFORMIDLINGS INSTITUTTET A/S is registered as an owner of ASTION PHARMA A/S with an ownership share of 100%.
ASTION PHARMA A/S has published its annual report for 2025. Gross profit came to DKK -18,071, and the net result was DKK -164,736.
ASTION PHARMA A/S has published its annual report for 2024. Gross profit came to DKK -115,576, and the net result was DKK -246,248.
ASTION PHARMA A/S has published its annual report for 2023. Gross profit came to DKK 132,462, and the net result was DKK 10,935.
ASTION PHARMA A/S has published its annual report for 2022. Gross profit came to DKK 206,156, and the net result was DKK 25,126.
ASTION PHARMA A/S has published its annual report for 2021. Gross profit came to DKK -1,354,194, and the net result was DKK -6,272,681.
ASTION PHARMA A/S has published its annual report for 2020. Gross profit came to DKK -3,602,554, and the net result was DKK -4,807,562.
As of March 22, 2021, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ASTION PHARMA A/S.
ASTION PHARMA A/S has published its annual report for 2019. Gross profit came to DKK -1,831,910, and the net result was DKK -1,767,025.
ASTION PHARMA A/S has published its annual report for 2018. Gross profit came to DKK -392,051, and the net result was DKK -409,449.
As of May 21, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of ASTION PHARMA A/S.
As of May 21, 2019, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ASTION PHARMA A/S.
As of September 1, 2018, Morten Bo Madsen is registered as director of ASTION PHARMA A/S.
As of September 1, 2018, Jan Kruse Hansen is registered as director of ASTION PHARMA A/S.
As of August 31, 2018, Jens Heimburger has stepped down as director of ASTION PHARMA A/S.
ASTION PHARMA A/S has published its annual report for 2017. Gross profit came to DKK -47,792, and the net result was DKK -1,543,930.
As of February 1, 2018, Ib Henrik Rønje has joined the board of directors of ASTION PHARMA A/S.
As of February 1, 2018, Torben Holger Schultz has left the board of directors of ASTION PHARMA A/S.
ASTION PHARMA A/S has published its annual report for 2016. Gross profit came to DKK -187,484, and the net result was DKK 116,538.
ASTION PHARMA A/S has published its annual report for 2015. Gross profit came to DKK -783,072, and the net result was DKK -5,768,474.
ASTION PHARMA A/S has published its annual report for 2014. Gross profit came to DKK -1,242,163, and the net result was DKK -3,436,228.
As of April 29, 2015, Torben Rønje has joined the board of directors of ASTION PHARMA A/S.
As of April 29, 2015, Torben Holger Schultz has joined the board of directors of ASTION PHARMA A/S.
As of April 29, 2015, Morten Weidner has left the board of directors of ASTION PHARMA A/S.
As of April 29, 2015, Søren Fjelrad Andersen has left the board of directors of ASTION PHARMA A/S.
As of April 28, 2015, Torben Rønje has left the board of directors of ASTION PHARMA A/S.
As of March 1, 2015, Jens Heimburger is registered as director of ASTION PHARMA A/S.
As of March 1, 2015, Morten Just Petersen has stepped down as director of ASTION PHARMA A/S.
ASTION PHARMA A/S has published its annual report for 2013. Gross profit came to DKK -804,182, and the net result was DKK -1,508,697.
As of May 1, 2014, Morten Just Petersen is registered as director of ASTION PHARMA A/S.
As of May 1, 2014, Morten Weidner has stepped down as director of ASTION PHARMA A/S.
ASTION PHARMA A/S has published its annual report for 2012. Gross profit came to DKK -1,109,724, and the net result was DKK -1,941,913.
As of November 5, 2012, Søren Fjelrad Andersen has joined the board of directors of ASTION PHARMA A/S.
As of November 5, 2012, Flemming Ørnskov has left the board of directors of ASTION PHARMA A/S.
On April 30, 2012, the company changed its name from AP NEWCO A/S to ASTION PHARMA A/S.
As of January 27, 2012, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of ASTION PHARMA A/S.
As of January 27, 2012, Torben Rønje has joined the board of directors of ASTION PHARMA A/S.
As of January 27, 2012, Jens Heimburger has joined the board of directors of ASTION PHARMA A/S.
As of January 27, 2012, Morten Weidner has joined the board of directors of ASTION PHARMA A/S.
As of January 27, 2012, Flemming Ørnskov has joined the board of directors of ASTION PHARMA A/S.
As of January 27, 2012, Morten Weidner is registered as director of ASTION PHARMA A/S.
ASTION PHARMA A/S was founded on January 27, 2012.
Companies in the same industry and area
CVR 42355933
CVR 30547217
CVR 37231444
CVR 35836926
CVR 35528598
